31.83
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TVTX?
Forum
Prognose
Aktiensplit
Travere Therapeutics Inc Aktie (TVTX) Neueste Nachrichten
Travere Therapeutics (TVTX) seeks approval to add 3M shares to 2018 equity plan - stocktitan.net
[144] Travere Therapeutics, Inc. SEC Filing - stocktitan.net
Travere Therapeutics (NASDAQ:TVTX) Shares Up 7.7%Still a Buy? - marketbeat.com
Travere Therapeutics (TVTX) Stock Rises Over 9% in Market Sessio - GuruFocus
Travere Therapeutics (TVTX) Stock Rises Over 9% in Market Session - gurufocus.com
TD Cowen Maintains Travere Therapeutics (TVTX) Buy Recommendation - MSN
Buyback Watch: Is Travere Therapeutics Inc trading at a discount2026 Macro Moves & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Palisades Investment Partners LLC Invests $5.26 Million in Travere Therapeutics, Inc. $TVTX - marketbeat.com
Travere Therapeutics (NASDAQ:TVTX) CEO Eric Dube Sells 60,000 Shares - marketbeat.com
Travere Therapeutics (NASDAQ:TVTX) Insider Sells $300,000.00 in Stock - marketbeat.com
Travere therapeutics CEO Dube sells $1.8m in TVTX stock By Investing.com - Investing.com Canada
Travere therapeutics chief legal officer sells $300k in TVTX stock - Investing.com
Travere therapeutics chief legal officer sells $300k in TVTX stock By Investing.com - Investing.com Australia
Travere Therapeutics (TVTX) CEO sells 60K shares after option exercise - stocktitan.net
Travere (NASDAQ: TVTX) CLO exercises options, pre-planned sale of 10K shares - stocktitan.net
Travere Awaits FDA FILSPARI Ruling As Valuation Gap Draws Attention - Yahoo Finance
(TVTX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
TVTX (NASDAQ: TVTX) files Form 144 for 60,000-share sale - stocktitan.net
Elizabeth Reed registers sale of 10,000 TVTX shares (TVTX) via option exercise - stocktitan.net
Hennion & Walsh Asset Management Inc. Increases Position in Travere Therapeutics, Inc. $TVTX - marketbeat.com
A Look At Travere Therapeutics (TVTX) Valuation After Recent Share Price Pullback - simplywall.st
Tudor Investment Corp Cuts Stake in Travere Therapeutics - National Today
Tudor Investment Corp ET AL Cuts Stake in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere, CSL gets standard EU approval for kidney disorder treatment - MSN
JPMorgan Chase Cuts Travere Therapeutics Price Target - National Today
Vanguard disaggregates holdings; reports 0 TVTX shares (Vanguard) - Stock Titan
Travere Therapeutics, Inc. $TVTX Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
J.P. Morgan Gives a Buy Rating to Travere Therapeutics (TVTX) - The Globe and Mail
Aug Spikes: Should value investors consider Travere Therapeutics Inc2026 Price Swings & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Travere Therapeutics price target lowered to $41 from $44 at JPMorgan - TipRanks
Earnings Risk: Is Cayson Acquisition Corp Equity Right stock a falling knife or bargain buy2026 Volatility Report & High Accuracy Swing Trade Signals - baoquankhu1.vn
FOMO Trade: Is Snail Inc forming bullish engulfing patternsMarket Trend Review & Weekly Top Gainers Trade List - baoquankhu1.vn
JPMorgan Chase & Co. Has Lowered Expectations for Travere Therapeutics (NASDAQ:TVTX) Stock Price - MarketBeat
JP Morgan Lowers Price Target for TVTX to $41.00, Maintains Over - GuruFocus
Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Travere Therapeutics (TVTX) Gains Attention with Potential FDA A - GuruFocus
Citi opens ‘upside 90-day catalyst watch’ on Travere Therapeutics - TipRanks
Citi Lifts Travere Therapeutics (TVTX) PT to $34 on Strong Q2 and Upcoming FDA Catalysts - MSN
A Look At Travere Therapeutics (TVTX) Valuation After Recent Share Price Volatility - simplywall.st
Travere Therapeutics (TVTX) reports 144% annual growth in Filspari sales for 2025 - MSN
Responsive Playbooks and the TVTX Inflection - Stock Traders Daily
Travere Therapeutics, Inc. (TVTX) positioned for long-term growth in rare disease market - MSN
Highs Report: Can Travere Therapeutics Inc be recession proofShare Buyback & Growth Focused Investment Plans - baoquankhu1.vn
Is Travere Therapeutics (TVTX) Pricing Signal An Opportunity After Recent Share Price Pullback? - simplywall.st
Travere Therapeutics Inc SEC Filings - Stock Titan
TVTX Earnings History & Surprises | EPS & Revenue Results | TRAVERE THERAPEUTICS INC (NASDAQ:TVTX) - ChartMill
Travere Therapeutics (NASDAQ:TVTX) Insider Sells $280,900.00 in Stock - MarketBeat
Travere Therapeutics (TVTX) CLO exercises options and sells 10K shares - Stock Titan
HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs - MSN
Cinctive Capital Management LP Makes New $2.26 Million Investment in Travere Therapeutics, Inc. $TVTX - MarketBeat
Earnings Recap: Is Travere Therapeutics Inc stock heavily shorted2026 Technical Patterns & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):